Exploring the Potential of GLP-1 Agonists in MASH
Introduction Metabolic-associated steatohepatitis (MASH) represents a significant health burden worldwide. This liver condition is strongly associated with obesity, type 2 diabetes, and other metabolic disorders. As research into metabolic health advances, GLP-1 agonists have emerged as a promising treatment for these conditions, extending their therapeutic benefits beyond diabetes and obesity management. This article explores the …
Exploring the Potential of GLP-1 Agonists in MASH Read More »